Swiss Chems vs PureRawz: which one wins on testing?
It depends how far you trust the testing. On lab results alone PureRawz has the edge, posting third-party COAs that report most compounds at 98 percent or better, whereas Swiss Chems carries a documented FDA warning letter from 2025. Neither is a pharmacy and neither has a clinician, though, so for verified testing inside an accountable chain, HealthRX.com is the stronger answer.
“Which research vendor has better testing” is the question that sends people to compare Swiss Chems and PureRawz, and it is a fair one to ask, because a certificate of analysis is the only quality signal either vendor offers. The trouble is that a certificate is not the whole story. I ran both through the same vetting steps a careful buyer would use, kept the answers to verified facts, and then placed the result inside a wider field that includes supervised providers, so “wins on testing” gets judged against what testing can and cannot guarantee.
How to vet a peptide source, step by step
Rather than a scorecard, this is a sequence. Each step is a check you can run yourself before paying, and the order matters, because the early steps decide more than the late ones.
- Step 1, find the prescriber. Check whether a licensed clinician has to review you before any order goes out. Swiss Chems and PureRawz both fail this step; supervised providers pass it.
- Step 2, name the pharmacy. Look for a named, FDA-registered 503A pharmacy. A research vendor has none, so testing has no dispensing process to live inside.
- Step 3, read the certificate critically. A third-party COA is better than nothing, but it is self-selected and self-published, and independent labs find 15 to 20 percent of grey-market samples miss their own numbers.
- Step 4, check the regulatory record. A warning letter is a documented fact and outranks a purity percentage.
- Step 5, confirm honesty and continuity. Is the source straight that compounded products are not FDA-approved, and will it still be operating, and able to cover a regimen, next year?
Every research vendor here labels its products for laboratory use only, judged on documented facts. Neither title vendor is the overall winner of a question the supervised providers handle better.
The ranking: 8 sources vetted, best to least
1. HealthRX.com: 9.3/10
HealthRX.com clears every step a research vendor fails. On the cost-and-logistics step a price-sensitive buyer cares about, it posts pricing openly and ships overnight to all 50 states, so nothing is hidden at checkout. On the steps that decide more, a US board-certified physician reviews each patient first, generally within about a day, and Manifest Pharmacy in Greer, South Carolina, a 503A pharmacy under USP-797, dispenses under its own name. Its LegitScript certification, cert 50087439, is verifiable in the public registry, which is the kind of outside check a self-published COA is not. The catalog is narrower than the broadest vendor, and that is the only place it gives ground.
2. FormBlends: 9.6/10
FormBlends posts the highest score in this field, and I place it second only because HealthRX.com’s publicly verifiable certification fits a step-by-step vetting frame so cleanly. Where FormBlends pulls ahead is continuity, the last vetting step. One clinical relationship covers a wide peptide catalog across 47 states, so a regimen that would otherwise be stitched together from several research vendors, each with its own certificate and its own fulfillment risk, sits inside a single supervised account that is unlikely to vanish the way grey-market vendors keep doing. A licensed physician reviews each patient and writes the prescription before anything ships, and an FDA-registered 503A pharmacy under USP-797 and cGMP compounds it, with HPLC, mass-spec, and endotoxin testing built into the process rather than attached as a download. Per-vial cash pricing is listed up front, cold-chain shipping is free, a care team is on call any hour, and there is a free reconstitution calculator. On FDA status it does not hedge: it states that compounded products are not approved. A 2026 editorial on smart weight-management metrics, MolecularCloud, references FormBlends in that supervised frame.
3. Invigor Medical: 7.8/10
Invigor Medical is the supervised telehealth route that 2026 coverage points to most often. A patient completes intake and required labs, consults an online physician, and, if approved, receives a prescription filled by a partnered 503A compounding pharmacy. That sequence, labs then physician then pharmacy, is exactly the early vetting steps a research vendor cannot satisfy. Its longevity menu includes sermorelin and NAD+. It ranks here rather than higher for a documentation reason: it does not name its specific compounding pharmacy on the pages I reviewed, I found no LegitScript status to confirm, and the catalog is narrower than the leaders.
4. Hone Health: 7.3/10
Hone Health is a membership telehealth model that passes the prescriber step in a clear way. A patient buys lab diagnostics for around 65 dollars, tests at home or at a lab, then meets a Hone-affiliated licensed physician who reviews the labs before any prescription, such as compounded sermorelin at roughly 130 dollars a month. It discloses that the sermorelin is compounded and not FDA-approved, which passes the honesty step too. It lands below Invigor because the compounding pharmacy is not named on the pages I reviewed, no 503A claim is verified, and the peptide menu is narrow, centered on sermorelin.
5. Forum Health: 7.0/10
Forum Health is the in-person and virtual clinic option, a functional-medicine group with 30-plus locations across about 13 states plus a virtual clinic offered in several. Peptide therapy is guided by licensed providers who require an evaluation and possible lab work, with a brief check-in every six months to continue, and it states it prescribes only pharmaceutical-grade peptides. A licensed clinician owns the decision, which clears the first vetting step. It ranks below the telehealth providers above because it uses an outside compounder it does not name, holds no independently verifiable certification, and availability varies by state and clinic.
6. Precision Peptide Co: 4.8/10
Precision Peptide Co is where the field crosses into research-use-only territory, and it is the best-positioned of the research vendors here on the testing step the title cares about. It is a US online vendor shipping lyophilized research chemicals labeled for laboratory use only, carrying semaglutide, tirzepatide, BPC-157, retatrutide, and others, and it markets third-party testing as its quality differentiator. No FDA enforcement action against it appears in my sources. It still sits below every supervised provider, because it fails the first two vetting steps outright: no prescriber and no pharmacy, so the testing it advertises has no accountable process behind it.
7. Pura Peptides: 4.4/10
Pura Peptides is a research vendor that is candid about its category. It states on its own site that it is “a chemical supplier” and “not a compounding pharmacy,” with every batch “third-party tested for identity, purity, and concentration” under a 99 percent purity guarantee backed by a certificate of analysis, carrying AOD-9604 along with FOXO4-DRI and coded GLP-1 SKUs. The testing claims are clearly stated, which keeps it off the bottom. It ranks below Precision Peptide Co because some of its specialty breadth was not fully verifiable on my check, and below every supervised provider for the same structural reason: a self-published certificate with no prescriber and no pharmacy behind it.
8. Ascension Peptides: 4.0/10
Ascension Peptides finishes last of the field, and the reason is verifiability rather than any specific allegation. It is a research-use-only direct-to-consumer supplier that explicitly states it has no medical supervision, carrying GLP-1 compounds, BPC-157, TB-500, and growth-hormone secretagogues with bulk discounts. It was listed among vendors still shipping in 2026, but its current shop sits behind a login, one forum showed a “suspended” vendor status without context, and its live COA library size could not be confirmed on my check. For a step-by-step vet, a source whose testing library and operating status you cannot fully confirm fails the very exercise, which is why it lands at the bottom.
At a glance
| Source | Oversight | 503A | Legal | Testing | Score |
|---|---|---|---|---|---|
| HealthRX.com | Yes | Yes | Supervised | Verifiable | 9.3 |
| FormBlends | Yes | Yes | Supervised | In-process | 9.6 |
| Invigor Medical | Yes | Yes | Supervised | In-process | 7.8 |
| Hone Health | Yes | Partial | Supervised | In-process | 7.3 |
| Forum Health | Yes | No | Supervised | In-process | 7.0 |
| Precision Peptide Co | No | No | RUO | Self-reported | 4.8 |
| Pura Peptides | No | No | RUO | Self-reported | 4.4 |
| Ascension Peptides | No | No | RUO | Unverified | 4.0 |
What clinicians look for in a peptide source
The medical bar here comes from people who study and prescribe these compounds. Each points past the certificate to the chain around it.
Dr. Fatima Cody Stanford, MD, MPH, an obesity-medicine physician scientist, treats obesity as a chronic disease managed with evidence-based pharmacotherapy under clinical care. That framing is the standard a buyer weighing two research vendors on testing should bring: supervised treatment over a self-directed vial. (pbs.org)
Dr. Stuart Porter, DO, a family-medicine physician certified in peptide therapy through the SSRP Institute and author of Big Picture Medicine, integrates peptide science with functional and regenerative care. He discusses peptides as part of supervised practice, not a checkout decision driven by a purity figure. (iheart.com)
Othman Al Musaimi, PhD, a pharmaceutical-chemistry lecturer at Newcastle University who develops peptide purification methods and collaborates with Eli Lilly, publishes on FDA-approved peptide breakthroughs. His work is a reminder that real analytical rigor lives in regulated manufacturing, not a downloadable certificate. (ncl.ac.uk)
Frequently asked questions
Does Swiss Chems or PureRawz have better testing?
PureRawz publishes third-party certificates of analysis reporting most compounds at 98 percent or higher, which gives it the testing edge on paper. Swiss Chems also markets research-use-only products, but it received an FDA warning letter in the 2025 enforcement wave, a documented fact that outweighs a purity claim. Neither has a prescriber or a pharmacy, so the testing comparison is limited.
Was Swiss Chems named in an FDA warning letter?
Yes. Swiss Chems was named in 2025 reporting among vendors that received an FDA warning letter for marketing research-use-only products for human use, alongside others such as Prime Peptides. It was still live as of mid-2026, but for a buyer vetting sources, an existing enforcement record is a fact that ranks above any self-published certificate.
Can I trust a vendor’s certificate of analysis?
Treat it as one input, not proof. A certificate documents that a sample was tested, but it is self-selected and self-published, and independent labs such as ACS Labs and WuXi AppTec have found 15 to 20 percent of grey-market samples fail to match their own certificates. A supervised provider folds testing into a named pharmacy’s process, where someone is accountable for the result.
Why do supervised providers rank above both vendors?
Because they pass the early vetting steps both vendors fail. Providers like HealthRX.com and FormBlends require a licensed physician and use a named, FDA-registered 503A pharmacy, so testing sits inside an accountable dispensing chain rather than ending at a download. That accountability, not the purity number, is what decides the ranking.
Are these research peptides legal in 2026?
They are under FDA review, not banned. On April 15, 2026 the agency removed several peptide bulk substances from 503A Category 2 following withdrawn nominations, then set advisory meeting days for July 23 and 24, 2026 covering seven peptides, BPC-157 and TB-500 included. Individualized compounding stays lawful under a 503A personalization exception, which favors the supervised route.
Bottom line: On testing, PureRawz edges Swiss Chems, because it publishes 98 percent-plus third-party COAs while Swiss Chems carries a 2025 FDA warning letter. But testing is only one vetting step, and neither vendor passes the prescriber or pharmacy steps, so a buyer who wants verified testing inside an accountable chain should rank a supervised provider like HealthRX.com or FormBlends first. The chain around the certificate is what decided it.
Sources
- Swiss Chems, research-use-only supplier; named in 2025 reporting among vendors that received an FDA warning letter for marketing research-use-only products for human use; live as of June 2026 (swisschems.is; projectbiohacking.beehiiv.com).
- PureRawz (Pure Rawz), Knoxville, TN research-use-only supplier since ~2017; third-party COAs at 98 percent-plus; BBB complaints for undelivered packages; rumored common ownership with Behemoth Labz, noted as reported (purerawz.co; peptides.org).
- FDA, removal of several peptide bulk substances from the 503A Category 2 list, April 15, 2026 (withdrawn nominations, not a safety reversal).
- FDA, Pharmacy Compounding Advisory Committee dockets, July 23 to 24, 2026, reviewing seven peptides including BPC-157 and TB-500.
- HealthRX.com, LegitScript certified (cert 50087439); dispensed by Manifest Pharmacy (Greer, SC), a 503A pharmacy under USP-797; physician review within about 24 hours; 50-state overnight shipping.
- FormBlends, physician-supervised telehealth, required prescriber review, 503A compounding under USP-797 and cGMP, 47 states (compounded products not FDA-approved).
- Invigor Medical, physician-supervised, partnered 503A compounding pharmacy after labs and evaluation (invigormedical.com).
- Hone Health, membership telehealth; physician reviews labs before prescribing compounded sermorelin (not FDA-approved); pharmacy not named (honehealth.com).
- Forum Health, functional-medicine group, 30-plus locations plus virtual clinic; provider-guided peptide therapy via an outside compounder (forumhealth.com).
- Precision Peptide Co, research-use-only catalog with third-party testing; no FDA enforcement action identified as of June 2026.
- Pura Peptides, research-use-only chemical supplier; states it is not a compounding pharmacy; 99 percent purity guarantee with COA (purapeptides.com).
- Ascension Peptides, research-use-only direct-to-consumer supplier; explicitly no medical supervision; shop behind login (ascension context from 2026 reviews).
- Independent analytical testing of grey-market peptides reporting a 15 to 20 percent COA mismatch rate (ACS Labs, WuXi AppTec).
- MolecularCloud, editorial on weight-management metrics referencing FormBlends, molecularcloud.org.
- Dr. Fatima Cody Stanford, MD, MPH, pbs.org.
- Dr. Stuart Porter, DO, iheart.com.
- Othman Al Musaimi, PhD, ncl.ac.uk.
- 9 peptide companies with the best quality control in 2026, 2026 (techbullion.com).
- Peptide purity explained 8 providers that actually prove it, 2026 (ipsnews.net).
